Hepatitis C Elimination: Opportunities and Challenges in 2023.

Taha, Gadeer; Ezra, Levy; Abu-Freha, Naim

Taha, Gadeer; Ezra, Levy; Abu-Freha, Naim.

Affiliation

Taha G; Department of Gastroenterology, Rambam Health Care Campus, Haifa 31096, Israel.
Ezra L; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel.
Abu-Freha N; Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Beer-Sheva 84101, Israel.

Viruses ; 15(7)2023 06 22.

Article in En | MEDLINE | ID: mdl-37515101

Subject(s)

Hepatitis C; Liver Transplantation; Humans; Hepacivirus/genetics; Antiviral Agents/therapeutic use; Hepatitis C/diagnosis; Hepatitis C/drug therapy; Hepatitis C/epidemiology; Liver Transplantation/adverse effects; Risk Factors

Key words

barriers; elimination; health system; hepatitis C; patients; provider

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Hepatitis C Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Viruses Year: 2023 Type: Article Affiliation country: Israel

Fulltext

XML

PubMed Links

Search on Google